Anti-Jka polyclonal 의 리콜

L’Agence nationale de sécurité du médicament et des produits de santé (ANSM)에 따르면, 해당 리콜 는 France 에서 Biotest 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 날짜
    2003-12-09
  • 사례 국가
  • 사례 출처
    ANSM
  • 사례 출처 URL
  • 비고 / 경고
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • 데이터 추가 비고
  • 조치
    Biotest withdraws from the market batches 1111201 (per.11.12.03), 1110902 (per.20.09.04) and 1110103 (per.17.01.05) of the in vitro diagnostic medical device called anti-Jka polyclonal - reference 808176, following a problem stability leading to a decline in the title over time and to obtain a lower than the required standards * .. This device of erythrocyte immunohematology, of human origin, is used for the research of the Jka erythrocyte antigen (antigen of the Kidd system). * The withdrawn lots are subject to the decree of February 8, 1984 relating to the characteristics and standards of the reagents used in erythrocyte immunology.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    in-vitro_medical_device
  • Manufacturer

Manufacturer

  • Source
    LAANSM